Title:Editorial: Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? (A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial)
Volume: 14
Issue: 5
Author(s): Vasilios G. Athyros, Niki Katsiki and Nikolaos Tentolouris
Affiliation:
Keywords:
Glucagon-like-peptide-1 receptor agonists, dipeptidyl peptidase 4 inhibitors, type 2 diabetes
mellitus, cardiovascular disease, heart failure.